Me- “My theory- mRNA vaccines don’t work past
Post# of 36537
(Total Views: 392)
Posted On: 08/13/2021 11:52:38 PM
Me- “My theory- mRNA vaccines don’t work past a few months, are risky and research showed they induced ZERO antibodies in the majority of transplant patients. Lots of “CYA.”
Figured I’d footnote myself from readings over a week to show not just rambling without researching:
1. Tuesday, August 10, 2021 NIH launches study of third COVID-19 vaccine dose in kidney transplant recipients. Trial will assess antibody response in people who did not respond to two-dose regimen. / NIAID Director Anthony S. Fauci, M.D., and Daniel Rotrosen, M.D., director of the NIAID Division of Allergy, Immunology, and Transplantation, are available to discuss the CPAT pilot study.
https://www.nih.gov/news-events/news-releases...recipients
Friday, August 13, 2021. CDC Panel Backs Third COVID Shot for the Immunocompromised. The ACIP recommends additional dose in moderately to severely immunocompromised people only. / In addition to solid-organ transplant recipients, CDC staff presented a potential list of other moderate to severe immunocompromising conditions that could qualify for an additional dose under the EUAs.
https://www.medpagetoday.com/infectiousdiseas...cine/94047
Extremely irresponsible timeline. A 3rd dose shouldn’t be recommended and given EU before the NIH study starts. Bizarre.
Figured I’d footnote myself from readings over a week to show not just rambling without researching:
1. Tuesday, August 10, 2021 NIH launches study of third COVID-19 vaccine dose in kidney transplant recipients. Trial will assess antibody response in people who did not respond to two-dose regimen. / NIAID Director Anthony S. Fauci, M.D., and Daniel Rotrosen, M.D., director of the NIAID Division of Allergy, Immunology, and Transplantation, are available to discuss the CPAT pilot study.
https://www.nih.gov/news-events/news-releases...recipients
Friday, August 13, 2021. CDC Panel Backs Third COVID Shot for the Immunocompromised. The ACIP recommends additional dose in moderately to severely immunocompromised people only. / In addition to solid-organ transplant recipients, CDC staff presented a potential list of other moderate to severe immunocompromising conditions that could qualify for an additional dose under the EUAs.
https://www.medpagetoday.com/infectiousdiseas...cine/94047
Extremely irresponsible timeline. A 3rd dose shouldn’t be recommended and given EU before the NIH study starts. Bizarre.
(4)
(0)Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼